نتایج جستجو برای: 131i radiotherapy
تعداد نتایج: 64118 فیلتر نتایج به سال:
OBJECTIVE Dosimetry studies have shown that activities of 131I as small as 10-20 MBq may cause a stunning effect. A result of this stunning effect may be a lower success rate of the ablative 131I therapy for differentiated thyroid carcinoma (DTC). The aim of this study was to determine whether pre-therapeutic uptake measurement with 40 MBq 131I causes a lower success rate of ablation. DESIGN ...
The conventional course of differentiated thyroid cancer (DTC) treatment requires surgical resection followed by radioactive iodine (131I) therapy (RAIT). Patients are advised to drink plenty water, as 131I gets eliminated through the kidneys and burden extra radiation is reduced. Treating a case DTC with chronic kidney disease (CKD) RAIT challenging. As result, when planning hemodialysis in pa...
Background: Anti-thyroid drugs (ATD) are routinely used in Australian practice as first-line therapy for Graves’ hyperthyroidism (GH) prior to 131I (radioiodine) treatment. There is concern that patients who do not receive ATD pre-treatment will develop uncontrolled hyperthyroidism before and after 131I therapy and that 131I therapy without ATD pre-treatment may not be as efficacious as with AT...
تهیه و بررسی پراکنش رادیوداروی پورفیرین استخلاف شده با رادیوایزوتوپ ید-131 جهت مقاصد تشخیصی و درمانی
اخیرا مشتقات پورفیرین توجه زیادی را به دلیل جذب بالای تومور، سمیت اندک و دفع سریع به عنوان رادیودارو، به صورت ترکیب نشاندار به خود جلب کرده اند. در این کار، نشاندارسازی ترکیب مزو- تتراکیس (پنتافلوئوروفنیل) به وسیله 131i رادیواکتیو را گزارش شد. ارزیابی بیولوژیکی ترکیب 131i-tfpp در موش مبتلا به تومور فیبروسارکوما، برای بررسی توانایی ترکیب به عنوان عامل تصویربرداری مطالعه شد. 131i-tfpp از طریق تشک...
We compared the diagnostic sensitivities of 123I and 131I whole-body imaging in differentiated thyroid cancer. Methods: Twelve thyroidectomized patients (3 previously treated with 131I) were studied. After a period of thyroid hormone withdrawal, whole-body imaging was performed approximately 24 and 72–96 h after administration of 74 –185 MBq (2–5 mCi) 123I and 111–185 MBq (3–5 mCi) 131I, respec...
BACKGROUND In our research,we study the effect of 131iodine-labeled histamine-indomethacin (131I-His-IN). We focus on its in vivo therapeutic effect and anti-tumor mechanisms in Lewis-bearing lung cancer. METHODS 131I-His-IN was administered by garage to the mice. At different timepoints, we made autoradiography (ARG) slices to observe the distribution of 131I-His-IN in the cellular, and the ...
A retrospective analysis of data from 73 consecutive patients with toxic multinodular goitre treated with iodine-131 (131I) during a 2-year period was performed to investigate if serum TSH at the time of 131I treatment influences the outcome. The dose of 131I was calculated according to a model compensating for thyroid size estimated by palpation and 24-h 131I uptake. Serum TSH was determined b...
Introduction To evaluate the clinical response rate after a postoperative 18F-FDG PET/CT guided external beam radiotherapy (EBRT) in Iodine-refractory differentiated thyroid cancer. Material and Methods Patients with thyroid cancer locally recurrent after total thyroidectomy plus metabolic radiotherapy and treated with radical EBRT were included. Inclusion criteria were detectable thyroglobul...
Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma
OBJECTIVE The aims of this study were to quantify the extent of volatilization from 131I-NaI therapeutic capsules prepared in a centralized radiopharmacy and to quantify the amount of volatile 131I released from a dispensing vial containing a compounded 131I-NaI therapy capsule. METHODS Therapy capsules were prepared by injecting 131I oral solution into capsules containing anhydrous dibasic s...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید